Thomas Mertz

438 total citations
16 papers, 285 citations indexed

About

Thomas Mertz is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Organic Chemistry. According to data from OpenAlex, Thomas Mertz has authored 16 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 2 papers in Organic Chemistry. Recurrent topics in Thomas Mertz's work include Atrial Fibrillation Management and Outcomes (4 papers), Cardiac Arrhythmias and Treatments (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Thomas Mertz is often cited by papers focused on Atrial Fibrillation Management and Outcomes (4 papers), Cardiac Arrhythmias and Treatments (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Thomas Mertz collaborates with scholars based in United States and Spain. Thomas Mertz's co-authors include Thomas B. McClanahan, Liguo Chi, Jeremy J. Edmunds, Stephen T. Rapundalo, Lakshmi Narasimhan, Wayne L. Cody, Debra R. Holland, Danette A. Dudley, J. Adam Willardsen and William C. Patt and has published in prestigious journals such as Journal of Medicinal Chemistry, The American Journal of Cardiology and European Journal of Pharmacology.

In The Last Decade

Thomas Mertz

16 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Mertz United States	8	150	80	62	30	27	16	285
Tammy C. Wang United States	10	113 0.8×	98 1.2×	46 0.7×	25 0.8×	52 1.9×	16	278
Hsingan Tsai United States	9	147 1.0×	73 0.9×	59 1.0×	4 0.1×	78 2.9×	11	283
Daisy Pireh United States	8	172 1.1×	119 1.5×	16 0.3×	5 0.2×	44 1.6×	14	347
Deborah A. Mischke United States	9	144 1.0×	133 1.7×	39 0.6×	35 1.2×	14 0.5×	12	258
Meredith A. Allen United States	8	71 0.5×	62 0.8×	18 0.3×	6 0.2×	15 0.6×	16	281
Joseph Cacciola United States	8	150 1.0×	80 1.0×	67 1.1×	2 0.1×	111 4.1×	10	304
Danette A. Dudley United States	7	195 1.3×	81 1.0×	30 0.5×	1 0.0×	43 1.6×	7	284
Y Shiokawa Japan	9	185 1.2×	105 1.3×	20 0.3×	74 2.5×	2 0.1×	33	333
Shuaige Wang United States	8	171 1.1×	80 1.0×	60 1.0×		103 3.8×	9	330

Countries citing papers authored by Thomas Mertz

Since Specialization

Citations

This map shows the geographic impact of Thomas Mertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mertz more than expected).

Fields of papers citing papers by Thomas Mertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Mertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mertz. The network helps show where Thomas Mertz may publish in the future.

Co-authorship network of co-authors of Thomas Mertz

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Mertz. A scholar is included among the top collaborators of Thomas Mertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Mertz. Thomas Mertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Bach, Stefan & Thomas Mertz. (2016). Vor der Erbschaftsteuerreform: Nutzung der Firmenprivilegien hat Minderjährige zu Multimillionären gemacht. Econstor (Econstor). 83(36). 812–820. 1 indexed citations

Pfefferkorn, Jeffrey A., Scott D. Larsen, Roderick J. Sorenson, et al.. (2007). Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption. Bioorganic & Medicinal Chemistry Letters. 18(2). 546–553. 18 indexed citations

Chi, Liguo, Glenn Gibson, Thomas Mertz, et al.. (2004). In Vitro and In Vivo Antithrombotic Activity of PD-198961, a Novel Synthetic Factor Xa Inhibitor. Journal of Cardiovascular Pharmacology. 44(4). 493–500. 7 indexed citations

Willardsen, J. Adam, Danette A. Dudley, Wayne L. Cody, et al.. (2004). Design, Synthesis, and Biological Activity of Potent and Selective Inhibitors of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 47(16). 4089–4099. 107 indexed citations

Chi, Liguo, Glenn Gibson, Thomas Mertz, et al.. (2002). Assessment of ex vivo Pharmacodynamic Markers during Inhibition of Thrombosis by CI-1031 (ZK-807834), a Novel Direct Factor Xa Inhibitor. Pharmacology. 64(2). 76–83. 2 indexed citations

McClanahan, Thomas B., et al.. (2001). The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis. European Journal of Pharmacology. 432(2-3). 187–194. 12 indexed citations

Chi, Liguo, Thomas Mertz, Nancy Janiczek, et al.. (2001). Antithrombotic Effect of LB-30057 (CI-1028), a New Synthetic Thrombin Inhibitor, in a Rabbit Model of Thrombosis: Comparison with Inogatran. Journal of Thrombosis and Thrombolysis. 11(1). 19–31. 4 indexed citations

Dudley, Danette A., Amy Bunker, Liguo Chi, et al.. (2000). Rational Design, Synthesis, and Biological Activity of Benzoxazinones as Novel Factor Xa Inhibitors. Journal of Medicinal Chemistry. 43(22). 4063–4070. 37 indexed citations

Chi, Liguo, et al.. (1998). A novel model of venous thrombosis in the vena cava of rabbits. Journal of Pharmacological and Toxicological Methods. 39(4). 193–202. 8 indexed citations

10.

Janiczek, Nancy, et al.. (1997). Pharmacokinetics and Pharmacodynamics of Pirmenol Enantiomers in Coronary Artery Ligated Dogs. Journal of Pharmaceutical Sciences. 86(4). 443–449. 2 indexed citations

11.

McClanahan, Thomas B., et al.. (1996). Effects of Endothelin-Receptor Antagonism with PD156707 on Myocardial Stunning in Swine. Journal of Cardiovascular Pharmacology. 28(5). 679–686. 6 indexed citations

12.

Gallagher, Kim P., Thomas B. McClanahan, Bradley J. Martin, et al.. (1995). Does Adenosine Deaminase Inhibition Protect Ischemic Myocardium?. Advances in experimental medicine and biology. 370. 291–294. 3 indexed citations

13.

Kaplan, Harvey, et al.. (1987). Preclinical pharmacology of pirmenol. The American Journal of Cardiology. 59(16). H2–H9. 9 indexed citations

14.

Taylor, Michael D., Walter H. Moos, Harriet W. Hamilton, et al.. (1986). Ribose-modified adenosine analogs as adenosine receptor agonists. Journal of Medicinal Chemistry. 29(3). 346–353. 37 indexed citations

15.

Mertz, Thomas, et al.. (1980). Pirmenol Hydrochloride (CI-845). Journal of Cardiovascular Pharmacology. 2(5). 527–542. 31 indexed citations

16.

Farah, Riad N., Richard C. Klugo, Thomas Mertz, & Joseph C. Cerny. (1978). Urological Complications in Renal Transplantation. 26(3). 35–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact